Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: A population-based cohort study in Italy

European Journal of Clinical Pharmacology

Volumn 67, Issue 3, 2011, Pages 289-299

  Corrao, Giovanni ^a   Romio, Silvana Antonietta ^a   Zambon, Antonella ^a   Merlino, Luca ^b   Bosi, Emanuele ^c   Scavini, Marina ^d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Operative Unit of Territorial Health Services   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Administrative database; Cohort study; Compliance; Insulin; Macrovascular complications; Metformin; Mortality; Oral hypoglycaemic agents; Persistence; Record linkage; Sulphonylurea

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIGITALIS GLYCOSIDE; INSULIN; METFORMIN; NITRATE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR DISEASE;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ITALY; MALE; MEDICATION ADHERENCE; METFORMIN; MIDDLE AGED; MODELS, BIOLOGICAL; PROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79954450059     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0939-6     Document Type: Article

References (54)

1. H King RE Aubert WH Herman 1998 Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1414 1431 1:STN:280:DyaK1czpsVyluw%3D%3D 10.2337/diacare.21.9.1414 9727886 (Pubitemid 28405191)
2. R Turner C Cull R Holman 1996 United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus Ann Intern Med 124 136 145 1:STN:280:DyaK287kslagsA%3D%3D 8554206 (Pubitemid 26011611)
3. Y Ohkubo H Kishikawa E Araki T Miyata S Isami S Motoyoshi Y Kojima N Furuyoshi M Shichiri 1995 Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Res Clin Pract 28 103 117 1:CAS:528:DyaK2MXpsVWgtrs%3D 10.1016/0168-8227(95)01064-K 7587918
4. S Vijan TP Hofer RA Hayward 1997 Estimated benefits of glycemic control in microvascular complications in type 2 diabetes Ann Intern Med 127 788 795 1:STN:280:DyaK1c%2FgtVOmtg%3D%3D 9382399 (Pubitemid 27465546)
5. B Gaster IB Hirsch 1998 The effects of improved glycemic control on complications in type 2 diabetes Arch Intern Med 158 134 140 1:STN:280:DyaK1c7htVSjsw%3D%3D 10.1001/archinte.158.2.134 9448551 (Pubitemid 28049506)
6. 33) Lancet 352 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
7. 34) Lancet 352 854 865 10.1016/S0140-6736(98)07037-8 (Pubitemid 28416719)
8. 35): prospective observational study BMJ 321 405 412 1:STN:280:DC%2BD3cvisFWnsg%3D%3D 10.1136/bmj.321.7258.405 10938048 (Pubitemid 30609442)
9. RR Holman SK Paul MA Bethel DR Matthews HA Neil 2008 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 1577 1589 1:CAS:528:DC%2BD1cXht1Wgt7nK 10.1056/NEJMoa0806470 18784090
10. CL Meinert GL Knatterud TE Prout CR Klimt 1970 A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results Diabetes 19 785 830
11. GL Knatterud CR Klimt ME Levin ME Jacobson MG Goldner 1978 Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment JAMA 240 37 42 1:STN:280:DyaE1c7pslajtw%3D%3D 10.1001/jama.240.1.37 351218 (Pubitemid 8395565)
12. C Kilo JP Miller JR Williamson 1980 The crux of the UGDP: spurious results and biologically inappropriate data analysis Diabetologia 18 179 185 1:STN:280:DyaL3c7otVWjsQ%3D%3D 10.1007/BF00251913 6989693
13. TB Schwartz CL Meinert 2004 The UGDP controversy: thirty-four years of contentious ambiguity laid to rest Perspect Biol Med 47 564 574 10.1353/pbm.2004.0071 15467178 (Pubitemid 39372366)
14. JA Johnson SH Simpson SR Majumdar EL Toth 2002 Decreased mortality associated with the use of metformin compared with sulphonylurea monotherapy in type 2 diabetes Diabetes Care 25 2244 2248 1:CAS:528:DC%2BD38Xps1Kks7s%3D 10.2337/diacare.25.12.2244 12453968 (Pubitemid 41071035)
15. JA Johnson SH Simpson EL Toth SR Majumdar 2005 Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes Diabet Med 22 497 502 1:STN:280:DC%2BD2M7lsFWjsQ%3D%3D 10.1111/j.1464-5491.2005.01448.x 15787679 (Pubitemid 40516253)
16. SH Simpson SR Majumdar RT Tsuyuki DT Eurich JA Johnson 2006 Dose-response relation between sulphonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study CMAJ 174 169 174 16415461 (Pubitemid 43166269)
17. JMM Evans SA Ogston A Emslie-Smith AD Morris 2006 Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin Diabetologia 49 930 936 1:CAS:528:DC%2BD28XjvFWrt7o%3D 10.1007/s00125-006-0176-9 16525843
18. I Tzoulaki M Molokhia V Curcin MP Little CJ Millett A Ng RI Hughes K Khunti MR Wilkins A Majeed P Elliott 2009 Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database BMJ 10.1136/bmj.b4731 19959591
19. EZ Fisman A Tenenbaum M Benderly U Goldbourt S Behar M Motro 1999 Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up Cardiology 91 195 202 1:CAS:528:DyaK1MXntVOnsbg%3D 10.1159/000006909 10516414 (Pubitemid 29454258)
20. J Olsson G Lindberg M Gottsäter K Lindwall A Sjöstrand A Tisell A Melander 2000 Increased mortality in type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study Diabetologia 43 558 560 1:CAS:528:DC%2BD3cXivV2ksbs%3D 10.1007/s001250051343 10855529 (Pubitemid 30322072)
21. 28) Diabetes Care 21 87 92 10.2337/diacare.21.1.87
22. EZ Fisman A Tenenbaum V Boyko M Benderly Y Adler A Friedensohn M Kohanovski R Rotzak H Schneider S Behar M Motro 2001 Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7 year follow-up Clin Cardiol 24 151 158 1:STN:280:DC%2BD3MvgvVCrtw%3D%3D 10.1002/clc.4960240210 11460818 (Pubitemid 32108625)
23. M Gulliford R Latinovic 2004 Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study Diabetes Metabol Res Rev 20 239 245 1:CAS:528:DC%2BD2cXltFOlu7k%3D 10.1002/dmrr.457 (Pubitemid 38714323)
24. KS Polonsky J Sturis GI Bell 1996 Non-insulin dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance N Engl J Med 334 777 783 1:CAS:528:DyaK28XitlKrsbo%3D 10.1056/NEJM199603213341207 8592553 (Pubitemid 26089361)
25. LC Groop R Pelkonen S Koskimies GF Bottazzo D Doniach 1986 Secondary failure to treatment with oral antidiabetic agents in non-insulin dependent diabetes mellitus Diabetes Care 9 129 133 1:STN:280:DyaL287ptFOktg%3D%3D 10.2337/diacare.9.2.129 3516607 (Pubitemid 16080466)
26. JA Spoelstra RP Stolk ER Heerdink OH Klungel JA Erkens HGM Leufkens DE Groobbe 2003 Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy? Pharmacoepidemiol Drug Saf 12 121 127 10.1002/pds.760 12642975 (Pubitemid 36304762)
27. G Corrao G Cesana L Merlino 2008 Pharmacoepidemiological research and the linking of electronic healthcare databases available in the Italian region of Lombardy Biomed Stat Clin Epidemiol 2 117 125
28. SJ Boccuzzi J Wogen J Fox JCY Sung AB Shah J Kim 2001 Utilization of oral hypoglycemic agents in a drug-insured US population Diabetes Care 24 1411 1415 1:STN:280:DC%2BD3MvktVOltg%3D%3D 10.2337/diacare.24.8.1411 11473078 (Pubitemid 33716429)
29. G Mazzaglia L Mantovani MC Sturkenboom A Filippi G Trifirò C Cricelli O Brignoli AP Caputi 2005 Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care J Hypertens 23 2093 2100 1:CAS:528: DC%2BD2MXhtVOitLbE 10.1097/01.hjh.0000186832.41125.8a 16208153 (Pubitemid 41830406)
30. TA Hillier KL Pedula 2003 Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth Diabetes Care 26 2999 3005 10.2337/diacare.26.11.2999 14578230 (Pubitemid 37345170)
31. PK Andersen N Keiding 2002 Multi-state models for event history analysis Stat Meth Med Res 11 91 115 10.1191/0962280202SM276ra (Pubitemid 34516542)
32. H Putter M Fiocco RB Geskus 2007 Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2389 2430 1:STN:280: DC%2BD2s3hs1agsA%3D%3D 10.1002/sim.2712 17031868 (Pubitemid 46730255)
33. H Putter J van der Hage GH de Bock R Elgalta CJH van de Velde 2006 Estimation and prediction in a multi-state model for breast cancer Biom J 3 366 380 10.1002/bimj.200510218 (Pubitemid 43973042)
34. DY Lin LJ Wei 1989 The robust inference for the Cox proportional hazards model J Am Stat Assoc 84 1074 1079 10.2307/2290085
35. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 613 619 1:STN:280:DyaK38zgtVeqsA%3D%3D 10.1016/0895-4356(92)90133-8 1607900
36. SAS Institute Inc. Release 8.1 enhancements to SAS/STAT software. Available at: http://support.sas.com/rnd/app/da/new/dastat81.html
37. D Boyle DR Hadden SK Bhatia DA Montgomery JA Weaver 1972 Ischaemic heart-disease in diabetics. A prospective study Lancet 7746 338 339 10.1016/S0140-6736(72)92839-5
38. DR Hadden DA Montgomery JA Weaver 1972 Myocardial infarction in maturity-onset diabetics. A retrospective study Lancet 7746 335 338 10.1016/S0140-6736(72)92838-3
39. NG Soler BL Pentecost MA Bennett MG FitzGerald P Lamb JM Malins 1974 Coronary care for myocardial infarction in diabetics Lancet 7856 475 477 10.1016/S0140-6736(74)92785-8
40. KN Garratt PA Brady NL Hassinger DE Grill A Terzic DR Holmes Jr 1999 Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction J Am Coll Cardiol 33 119 124 1:CAS:528:DyaK1MXpvV2nsw%3D%3D 10.1016/S0735-1097(98)00557-9 9935017 (Pubitemid 29064081)
41. I Gustafsson P Hildebrandt M Seibaek T Melchior C Torp-Pedersen L Køber P Kaiser-Nielsen 2000 Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group Eur Heart J 21 1937 1943 1:STN:280:DC%2BD3M7jslWgsg%3D%3D 10.1053/euhj.2000.2244 11071799
42. WS Aronow C Ahn 2001 Incidence of new coronary events in older persons with diabetes mellitus and prior myocardial infarction treated with sulfonylureas, insulin, metformin, and diet alone Am J Cardiol 88 556 557 1:STN:280:DC%2BD3MvotVOlsg%3D%3D 10.1016/S0002-9149(01)01739-8 11524069 (Pubitemid 32778506)
43. JH O'Keefe EH Blackstone P Sergeant BD McCallister 1998 The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery Eur Heart J 19 1696 1703 10.1053/euhj.1998.1153 9857923 (Pubitemid 28524189)
44. H Thisted SP Johsen J Rungby 2006 Sulfonylureas and the risk of myocardial infarction Metabolism 55 S16 S19 1:CAS:528:DC%2BD28XjvValtL4%3D 10.1016/j.metabol.2006.02.004 16631805
45. G Leibowitz E Cerasi 1996 Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia 39 503 514 1:CAS:528:DyaK28XjtlSis70%3D 10.1007/BF00403296 8739909 (Pubitemid 26135453)
46. M Coutinho Y Wang HC Gerstein S Yusuf 1999 The relationship between glucose and incident cardiovascular events Diabetes Care 22 233 240 1:STN:280:DyaK1M3ms1Crsw%3D%3D 10.2337/diacare.22.2.233 10333939 (Pubitemid 29056916)
47. S Bolen L Feldman J Vassy L Wilson H-C Yeh S Marinopulos C Wiley E Selvin R Wilson EB Bass FL Brancati 2007 Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus Ann Intern Med 147 386 399 17638715 (Pubitemid 351664540)
48. DM Nathan JB Buse MB Davidson E Ferrannini RR Holman R Sherwin B Zinman 2009 Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 193 203 1:CAS:528:DC%2BD1MXhs1Gns78%3D 10.2337/dc08-9025 18945920
49. TL Skaer DA Selar DJ Markowski JKH Won 1993 Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures-a study of patients with non-insulin-dependent diabetes mellitus J Clin Pharm Ther 18 295 299 1:STN:280:DyaK2c%2FktlGqsA%3D%3D 10.1111/j.1365-2710. 1993.tb00591.x 8227238 (Pubitemid 23235099)
50. AHP Paes A Bakker CJ Soe-Agnie 1997 Impact of dosage frequency on patient compliance Diabetes Care 20 1512 1517 1:STN:280:DyaK2svmtVajsw%3D%3D 10.2337/diacare.20.10.1512 9314626 (Pubitemid 27415025)
51. AHP Paes A Bakker CJ Soe-Agnie 1998 Measurement of patient compliance Pharm World Sci 20 73 77 1:STN:280:DyaK1c3ksFeiuw%3D%3D 10.1023/A:1008663215166 9584340 (Pubitemid 28228437)
52. F Venturini MB Nichol JCY Sung KL Bailey M Cody JS McCombs 1999 Compliance with sulfonylureas in a health maintenance organization: a pharmacy-record based study Ann Pharmacother 33 281 288 1:STN:280: DyaK1M3hs1ymtQ%3D%3D 10.1345/aph.18198 10200850 (Pubitemid 29157736)
53. G Corrao A Zambon F Nicotra V Bagnardi C Fornari C La Vecchia M Mezzanzanica RE Nappi L Merlino G Cesana 2007 Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes Maturitas 57 315 324 1:CAS:528:DC%2BD2sXmsFChsbg%3D 10.1016/j.maturitas.2007.03.001 17485182 (Pubitemid 46891706)
54. KS Burgers JV Bailey NS Klazinga AK Van Der Bij R Grol G Feder for the Agree Collaboration 2002 Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries Diabetes Care 25 1933 1939 10.2337/diacare.25.11.1933 12401735 (Pubitemid 41071047)